Cullinan Therapeutics(CGEM)_个股概要_股票价格_最新资讯_行情走势_历史数据

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

CGEM Cullinan Therapeutics

交易中 12-19 10:35:57 EST

10.69

-0.08

-0.74%

最高10.96	最低10.45	成交量10.35万
今开10.94	昨收10.77	日振幅4.69%
总市值6.22亿	流通市值4.12亿	总股本5,823万
成交额110.48万	换手率0.27%	流通股本3,854万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"CGEM","market":"US","secType":"STK","nameCN":"Cullinan Therapeutics","latestPrice":10.69,"timestamp":1734622535400,"preClose":10.77,"halted":0,"volume":103470,"delay":0,"floatShares":38538089,"shares":58227593,"eps":-2.884299,"marketStatus":"交易中","marketStatusCode":2,"change":-0.08,"latestTime":"12-19 10:35:57 EST","open":10.94,"high":10.955,"low":10.45,"amount":1104811.272,"amplitude":0.04689,"askPrice":10.72,"askSize":320,"bidPrice":10.66,"bidSize":10,"shortable":3,"etf":0,"ttmEps":-2.884299,"exchange":"NASDAQ","tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1734642000000},"adr":0,"listingDate":1610082000000,"adjPreClose":10.77,"preHourTrading":{"tag":"盘前","latestPrice":10.93,"preClose":10.77,"latestTime":"09:04 EST","volume":443,"amount":4880.989948,"timestamp":1734617083029},"postHourTrading":{"tag":"盘后","latestPrice":11.2,"preClose":10.77,"latestTime":"17:39 EST","volume":163381,"amount":1759090.91,"timestamp":1734561544109},"volumeRatio":1.369364,"impliedVol":2.4577,"impliedVolPercentile":0.996},"requestUrl":"/m/hq/s/CGEM/wiki","defaultTab":"wiki","newsList":[{"id":"2486588356","title":"Cullinan Therapeutics, Inc.盘中异动 急速拉升5.14%报13.19美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2486588356","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486588356?lang=zh_cn&edition=full","pubTime":"2024-11-27 00:03","pubTimestamp":1732636993,"startTime":"0","endTime":"0","summary":"北京时间2024年11月27日00时03分，Cullinan Therapeutics, Inc.股票出现波动，股价急速拉升5.14%。截至发稿，该股报13.19美元/股，成交量12.0849万股，换手率0.21%，振幅4.47%。Cullinan Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.22%。其相关个股中，Poseida Therapeutics, Inc.、Lexaria Bioscience Corp C/Wts 14/01/2026 、Ventyx Biosciences, Inc.涨幅较大，Elevai Labs, Inc.、木薯科学、Poseida Therapeutics, Inc.较为活跃，换手率分别为38.16%、25.56%、21.93%，振幅较大的相关个股有Rocket Pharmaceuticals Inc C/Wts 02/09/2026 、Tc Biopharm  Plc C/Wts 10/02/2028 、Protagenic Therapeutics, Inc.，振幅分别为85.82%、50.00%、42.94%。Cullinan Therapeutics, Inc.公司简介：Cullinan Therapeutics Inc是一家生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112700031398e44b6e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112700031398e44b6e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CGEM","LENZ"],"gpt_icon":0},{"id":"2484960389","title":"美国研究综述-Equifax、Microstrategy、Netflix","url":"https://stock-news.laohu8.com/highlight/detail?id=2484960389","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484960389?lang=zh_cn&edition=full","pubTime":"2024-11-19 15:10","pubTimestamp":1732000212,"startTime":"0","endTime":"0","summary":"美国研究综述-Equifax、Microstrategy、Netflix路透11月19日 - 华尔街证券分析师周二调整了对几家美国上市公司的评级和目标价，其中包括 Equifax、Microstrategy 和 Netflix。要闻  * 凯斯百货公司CASY.O：杰富瑞将目标价从 450 美元上调至 470 美元 * Equifax Inc EFX.N：摩根大通将目标价从304美元下调至283美元 * Microstrategy Inc MSTR.O：Benchmark将目标价从300美元上调至450美元 * Netflix Inc NFLX.O：杰富瑞将目标价从800美元上调至1000美元 * Palo Alto Networks Inc PANW.O：杰富瑞将目标价从400美元上调至450美元以下是路透周二报道的美国公司研究报告摘要。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241119:nL4S3MQ0JJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4107","LU2237957902.USD","MRNA","BK4077","LU2326559502.SGD","NFLX","KYMR","CHPT","LU2249611893.SGD","MOS","BK4113","WSM","LU1571399168.USD","VRT","LU1046421795.USD","PTCT","BK4585","PLUG","LU1670710661.SGD","LU0109394709.USD","ACRS","CPRT","FTNT","MSTR","PANW","LOVE","QS","KHC","CPRX","FENC","IDYA","KMPR","RGNX","BECN","LU1429558221.USD","CGEM","CASY","RDDT","CCCC","ARVN","EFX","IE00BQXX3C00.GBP","LU0106261372.USD","DCOM","RC","MEOH","FNV","BK4588","EHAB"],"gpt_icon":1},{"id":"2484385988","title":"Cullinan Therapeutics, Inc.盘中异动 股价大跌5.19%报13.14美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2484385988","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484385988?lang=zh_cn&edition=full","pubTime":"2024-11-19 03:23","pubTimestamp":1731957785,"startTime":"0","endTime":"0","summary":"北京时间2024年11月19日03时23分，Cullinan Therapeutics, Inc.股票出现异动，股价急速下跌5.19%。截至发稿，该股报13.14美元/股，成交量26.9188万股，换手率0.46%，振幅6.31%。Cullinan Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.03%。其相关个股中，Hcw Biologics Inc.、冠科美博、Apollomics Inc C/Wts 01/04/2028 涨幅较大，冠科美博、Hcw Biologics Inc.、Tharimmune, Inc.较为活跃，换手率分别为1399.01%、1260.16%、569.88%，振幅较大的相关个股有Hcw Biologics Inc.、冠科美博、Apollomics Inc C/Wts 01/04/2028 ，振幅分别为563.48%、221.58%、193.44%。Cullinan Therapeutics, Inc.公司简介：Cullinan Therapeutics Inc是一家生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241119032306a243a5ed&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241119032306a243a5ed&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CGEM","BK4139","LENZ"],"gpt_icon":0},{"id":"2481102978","title":"Cullinan Therapeutics, Inc.盘中异动 急速上涨5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2481102978","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481102978?lang=zh_cn&edition=full","pubTime":"2024-11-08 22:46","pubTimestamp":1731077177,"startTime":"0","endTime":"0","summary":"北京时间2024年11月08日22时46分，Cullinan Therapeutics, Inc.股票出现异动，股价快速上涨5.01%。截至发稿，该股报16.36美元/股，成交量4.1812万股，换手率0.07%，振幅3.34%。Cullinan Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.44%。其相关个股中，Fortrea Holdings Inc.、Lipella Pharmaceuticals Inc.、Matinas Biopharma Holdings, Inc.涨幅较大，Elevai Labs, Inc.、Matinas Biopharma Holdings, Inc.、Lipella Pharmaceuticals Inc.较为活跃，换手率分别为462.02%、39.55%、23.24%，振幅较大的相关个股有Psyence Biomedical Ltd C/Wts 25/01/2029、Tevogen Bio Holdings Inc C/Wts 14/02/2029 、Lipella Pharmaceuticals Inc.，振幅分别为86.00%、31.72%、29.95%。Cullinan Therapeutics, Inc.公司简介：Cullinan Therapeutics Inc是一家生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110822461798e417d8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110822461798e417d8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CGEM","BK4139","LENZ"],"gpt_icon":0},{"id":"2480558024","title":"库里南治疗公司  预计每股亏损81美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2480558024","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480558024?lang=zh_cn&edition=full","pubTime":"2024-11-04 23:47","pubTimestamp":1730735252,"startTime":"0","endTime":"0","summary":"   * 预计库里南治疗公司   在11月6日公布截至2024年9月30日的业绩时，季度收入将没有变化(预计)。*    * LSEG分析师对Cullinan Therapeutics Inc的平均预期是每股亏损81美分。* 华尔街对 Cullinan Therapeutics Inc 的 12 个月目标价中位数为 30.00 美元，高于其上次收盘价 15.78 美元。11月4日 - 以往季度业绩。除非另有说明，否则所有数据均以美元为单位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"库里南治疗公司  预计每股亏损81美分 - 财报前瞻","news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CGEM"],"gpt_icon":0},{"id":"2475683560","title":"Cullinan Therapeutics, Inc.盘中异动 股价大涨5.98%","url":"https://stock-news.laohu8.com/highlight/detail?id=2475683560","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2475683560?lang=zh_cn&edition=full","pubTime":"2024-10-15 21:31","pubTimestamp":1728999078,"startTime":"0","endTime":"0","summary":"北京时间2024年10月15日21时31分，Cullinan Therapeutics, Inc.股票出现波动，股价快速上涨5.98%。截至发稿，该股报17.20美元/股，成交量2250股，换手率0.00%，振幅1.11%。Cullinan Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.11%。其相关个股中，Apollomics Inc C/Wts 01/04/2028 、60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 、Psyence Biomedical Ltd C/Wts 25/01/2029涨幅较大，Lipella Pharmaceuticals Inc.、Enveric Biosciences, Inc.、Gritstone Bio, Inc.较为活跃，换手率分别为238.21%、163.82%、125.12%，振幅较大的相关个股有Notable Labs, Ltd.、Bright Minds Biosciences Inc.、Genprex, Inc.，振幅分别为12.25%、10.04%、7.99%。Cullinan Therapeutics, Inc.公司简介：Cullinan Therapeutics Inc是一家生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024101521311898e3c860&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024101521311898e3c860&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CGEM","LENZ"],"gpt_icon":0},{"id":"2470163449","title":"Cullinan Therapeutics, Inc.盘中异动 临近收盘股价大涨5.11%报17.48美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2470163449","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2470163449?lang=zh_cn&edition=full","pubTime":"2024-09-25 03:50","pubTimestamp":1727207406,"startTime":"0","endTime":"0","summary":"北京时间2024年09月25日03时50分，Cullinan Therapeutics, Inc.股票出现异动，股价快速拉升5.11%。截至发稿，该股报17.48美元/股，成交量53.7769万股，换手率0.93%，振幅5.23%。Cullinan Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.61%。Cullinan Therapeutics, Inc.公司简介：Cullinan Therapeutics Inc是一家生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240925035006ab65b012&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240925035006ab65b012&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","CGEM"],"gpt_icon":0},{"id":"2460305401","title":"Cullinan Therapeutics, Inc.盘中异动 下午盘急速上涨5.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2460305401","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2460305401?lang=zh_cn&edition=full","pubTime":"2024-08-20 01:05","pubTimestamp":1724087109,"startTime":"0","endTime":"0","summary":"北京时间2024年08月20日01时05分，Cullinan Therapeutics, Inc.股票出现波动，股价大幅拉升5.03%。截至发稿，该股报17.55美元/股，成交量15.6339万股，换手率0.27%，振幅5.15%。Cullinan Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.94%。其相关个股中，Alzamend Neuro, Inc.、Virax Biolabs Group Limited、Geovax Labs Inc C/Wts 29/09/2025涨幅较大，Alzamend Neuro, Inc.、Virax Biolabs Group Limited、Tonix Pharmaceuticals Holding Corp.较为活跃，换手率分别为7738.25%、3522.27%、1130.06%，振幅较大的相关个股有Alzamend Neuro, Inc.、Virax Biolabs Group Limited、Revelation Biosciences Inc C/Wts 10/01/2027 ，振幅分别为405.90%、220.18%、198.02%。Cullinan Therapeutics, Inc.公司简介：Cullinan Therapeutics Inc是一家生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024082001050998e35656&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024082001050998e35656&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","CGEM"],"gpt_icon":0},{"id":"2460249429","title":"Cullinan Therapeutics, Inc.2024财年第二财季实现净利润-42.03百万美元，同比减少30.49%","url":"https://stock-news.laohu8.com/highlight/detail?id=2460249429","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2460249429?lang=zh_cn&edition=full","pubTime":"2024-08-17 00:00","pubTimestamp":1723824039,"startTime":"0","endTime":"0","summary":"8月17日，Cullinan Therapeutics, Inc.公布财报，公告显示公司2024财年第二财季净利润为-42.03百万美元，同比减少30.49%；其中营业收入为0.00美元，每股基本收益为-0.76美元。从资产负债表来看，Cullinan Therapeutics, Inc.总负债25.00百万美元，其中短期债务1.22百万美元，资产负债比为0.28，流动比率为0.29。机构评级：截至2024年8月17日，当前有7家机构对Cullinan Therapeutics, Inc.目标价做出预测，其中目标均价为32.71美元，其中最低目标价为28.00美元，最高目标价为40.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240817000618959f2d73&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240817000618959f2d73&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CGEM","LENZ"],"gpt_icon":0},{"id":"2457780014","title":"库里南治疗公司  预计每股亏损73美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2457780014","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457780014?lang=zh_cn&edition=full","pubTime":"2024-08-06 18:51","pubTimestamp":1722941474,"startTime":"0","endTime":"0","summary":"   * Cullinan Therapeutics Inc    预计在8月8日公布截至2024年6月30日的业绩时，季度收入不会有变化(预计)    *    * LSEG分析师对Cullinan Therapeutics Inc的平均预期是每股亏损73美分。* 目前，分析师对该公司股票的平均评级为 \"强力买入\"，建议分类为9个 \"强力买入 \"或 \"买入\"，没有 \"持有\"，也没有 \"卖出 \"或 \"强力卖出\"。* 华尔街对 Cullinan Therapeutics Inc 的 12 个月目标价中位数为 30.00 美元，高于其上次收盘价 17.55 美元。8月6日 - 以往季度业绩。除非另有说明，所有数字均以美元为单位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"库里南治疗公司  预计每股亏损73美分 - 财报前瞻","news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CGEM"],"gpt_icon":0},{"id":"2456284220","title":"Cullinan Therapeutics, Inc.盘中异动 早盘大幅跳水9.54%报16.97美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2456284220","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2456284220?lang=zh_cn&edition=full","pubTime":"2024-08-02 21:33","pubTimestamp":1722605625,"startTime":"0","endTime":"0","summary":"北京时间2024年08月02日21时33分，Cullinan Therapeutics, Inc.股票出现波动，股价快速下跌9.54%。截至发稿，该股报16.97美元/股，成交量1.2117万股，换手率0.02%，振幅2.53%。Cullinan Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.52%。其相关个股中，Exicure, Inc.、Os Therapies Incorporated、Dermata Therapeutics, Inc.涨幅较大，Exicure, Inc.、Dermata Therapeutics, Inc.、Cns Pharmaceuticals, Inc.较为活跃，换手率分别为330.21%、92.40%、20.52%，振幅较大的相关个股有Exicure, Inc.、Anew Medical Inc C/Wts 21/06/2029 、Dermata Therapeutics, Inc.，振幅分别为33.34%、17.87%、16.46%。Cullinan Therapeutics, Inc.公司简介：Cullinan Therapeutics Inc是一家生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024080221334695780d69&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024080221334695780d69&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CGEM","LENZ"],"gpt_icon":0},{"id":"2453799789","title":"Cullinan Therapeutics, Inc.盘中异动 急速拉升5.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2453799789","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2453799789?lang=zh_cn&edition=full","pubTime":"2024-07-22 22:26","pubTimestamp":1721658406,"startTime":"0","endTime":"0","summary":"北京时间2024年07月22日22时26分，Cullinan Therapeutics, Inc.股票出现波动，股价大幅拉升5.03%。截至发稿，该股报19.21美元/股，成交量19.6245万股，换手率0.34%，振幅4.43%。Cullinan Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.46%。其相关个股中，Coeptis Therapeutics Holdings Inc C/Wts 31/12/2024 、Apollomics Inc C/Wts 01/04/2028 、木薯科学涨幅较大，Hepion Pharmaceuticals, Inc.、Scisparc Ltd.、Virpax Pharmaceuticals, Inc.较为活跃，换手率分别为111.66%、97.09%、30.14%，振幅较大的相关个股有Anew Medical Inc C/Wts 21/06/2029 、木薯科学、Hepion Pharmaceuticals, Inc.，振幅分别为44.07%、29.96%、27.45%。Cullinan Therapeutics, Inc.公司简介：Cullinan Therapeutics Inc是一家生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240722222646aefacba4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240722222646aefacba4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","CGEM"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.cullinantherapeutics.com","stockEarnings":[{"period":"1week","weight":-0.1398},{"period":"1month","weight":-0.1993},{"period":"3month","weight":-0.3997},{"period":"6month","weight":-0.3821},{"period":"1year","weight":0.1732},{"period":"ytd","weight":0.0569}],"compareEarnings":[{"period":"1week","weight":-0.0349},{"period":"1month","weight":-0.0032},{"period":"3month","weight":0.0268},{"period":"6month","weight":0.0767},{"period":"1year","weight":0.2347},{"period":"ytd","weight":0.2335}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Cullinan Therapeutics, Inc.于特拉华州注册成立。该公司是一家生物制药公司，专注于为癌症患者开发具有转化潜力的肿瘤靶向治疗和免疫肿瘤治疗的多样化渠道。","yearOnYearQuotes":[{"month":1,"riseRate":0.666667,"avgChangeRate":0.154237},{"month":2,"riseRate":0.75,"avgChangeRate":0.07927},{"month":3,"riseRate":0.25,"avgChangeRate":-0.102565},{"month":4,"riseRate":0.25,"avgChangeRate":0.06304},{"month":5,"riseRate":0.5,"avgChangeRate":-0.016956},{"month":6,"riseRate":0.5,"avgChangeRate":-0.036449},{"month":7,"riseRate":0.5,"avgChangeRate":0.009507},{"month":8,"riseRate":0.5,"avgChangeRate":0.054684},{"month":9,"riseRate":0,"avgChangeRate":-0.130174},{"month":10,"riseRate":0.5,"avgChangeRate":-0.007673},{"month":11,"riseRate":0,"avgChangeRate":-0.125297},{"month":12,"riseRate":0.25,"avgChangeRate":-0.06227}],"exchange":"NASDAQ","name":"Cullinan Therapeutics","nameEN":"Cullinan Therapeutics"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Cullinan Therapeutics(CGEM)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Cullinan Therapeutics(CGEM)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Cullinan Therapeutics,CGEM,Cullinan Therapeutics股票,Cullinan Therapeutics股票老虎,Cullinan Therapeutics股票老虎国际,Cullinan Therapeutics行情,Cullinan Therapeutics股票行情,Cullinan Therapeutics股价,Cullinan Therapeutics股市,Cullinan Therapeutics股票价格,Cullinan Therapeutics股票交易,Cullinan Therapeutics股票购买,Cullinan Therapeutics股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Cullinan Therapeutics(CGEM)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Cullinan Therapeutics(CGEM)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}

公司概况